Librarian at Your Service LLC

The Institute for Healthcare Optimization (IHO) is dedicated to enhancing healthcare delivery through innovative strategies that optimize operations and improve patient outcomes. By focusing on artificial variability and flow optimization, IHO aims to bridge the gap between healthcare delivery and management science while addressing critical issues such as cost reduction and quality improvement. Generated from the website

MAKScientific is a Boston-based pharmaceutical company that is dedicated to developing drugs targeting the endocannabinoid system to treat various medical disorders. With a focus on selective targeting of components such as cannabinoid receptors and enzymes, they have a growing portfolio of small molecule modulators that have shown promise in animal models of human disease. One of their advanced drug candidates, AM6545, is a peripherally restricted CB1 receptor antagonist that offers a potential new approach to managing chronic liver disease and metabolic disorders. Seeking a partner for further development and commercialization, MAKScientific has already advanced this drug candidate to the late pre-clinical stage with no adverse pre-clinical data to date.Generated from the website

Aphios Corporation is a biopharmaceutical company that develops enhanced natural therapeutics for infectious diseases, cancer and quality-of-life medicines. The company s business strategy is to collaborate with multinational companies, such as Novartis, Bayer, Bristol-Myers Squibb, Eli Lilly and the Gillette Company, to develop enhanced therapeutic products. The resulting technology platforms and therapeutic products have garnered approximately 30 United States and international patents with several applications pending. Its product pipeline includes SuperCool Gingerol, a pill for aiding digestion; Zindol, a pill that mitigates nausea caused by chemotherapy and motion and morning sickness; Xantol, a pill to treat mild to moderate depression and anxiety; and LoTax, an intravenous medication for breast and ovarian cancer. Aphios is also developing antiviral therapeutics against HIV, influenza, smallpox and SARS. The company maintains its headquarters in Woburn, Mass.